Ken Griffin Capricor Therapeutics, Inc. Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
8 transactions
Others Institutions Holding CAPR
# of Institutions
70Shares Held
6.31MCall Options Held
210KPut Options Held
526K-
Black Rock Inc. New York, NY1.63MShares$31.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$29.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$12.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$9.26 Million0.0% of portfolio
-
State Street Corp Boston, MA401KShares$7.75 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $470M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...